Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal BRCA1-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy

Authors: A. I. Stukan, Z. K. Khachmamuk, V. V. Antipova, A. V. Dzagashtokova

Source: Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 78-88 (2022)

Subject Terms: estrogen receptor alpha, progesterone receptors, loss of estrogen receptor expression, luminal phenotype, brca1-associated breast cancer, parp inhibitor, talazoparib, Gynecology and obstetrics, RG1-991

File Description: electronic resource

Relation: https://ojrs.abvpress.ru/ojrs/article/view/999; https://doaj.org/toc/1994-4098; https://doaj.org/toc/1999-8627

Access URL: https://doaj.org/article/47724076f13b4d7cb602c36160806794